MedPath

Alembic Pharmaceuticals Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

163

FDA:163

Drug Approvals

Amantadine

Approval Date
Jul 28, 2025
FDA

DOXEPIN HYDROCHLORIDE

Approval Date
Jul 17, 2025
FDA

Amlodipine and Atorvastatin

Approval Date
May 23, 2025
FDA

Ticagrelor

Approval Date
May 7, 2025
FDA

CARBAMAZEPINE

Approval Date
Apr 22, 2025
FDA

CLINDAMYCIN PHOSPHATE

Approval Date
Apr 4, 2024
FDA

CLOBETASOL PROPIONATE

Approval Date
Mar 14, 2024
FDA

Clobetasol Propionate

Approval Date
Mar 1, 2024
FDA

Azithromycin

Approval Date
Feb 22, 2024
FDA

Zolmitriptan

Approval Date
Feb 20, 2024
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 17
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.